"Inequitable Conduct" Standard for Patent Suits is Heightened
'Women in Law Report' Findings
A Contrarian View of MedImmune v. Genentech
A Law Firm's Technical Specialist Program Exceeds Expectations
A Long-Term View: Software Should Be Patentable in Europe
Click here to access the Web site housing this article.
A Patented Formula for IP Success
A Review of "The Dance of Molecules"
Advisory - USPTO Publishes "Changes to Practice for Continued Examination Filings"
The United States Patent and Trademark Office has published a final rulemaking that greatly changes current prosecution practice. Entitled, "Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably indistinct Claims, and Examination of Claims in Patent Applications," the rulemaking was published on August 21, 2007 at 72 Fed. Reg. 46716.
Although it is effective November 1, 2007, it impacts most patent applications that are currently on file. It is a complex rulemaking, and quite importantly, some aspects are retroactive.
All or One Under the Doctrine of Equivalents
An Interview With: Tracy-Gene Durkin, President, Women's Bar Association of the District of Columbia
Click here to access the Web site housing this article.
An Overview of the Technology Transfer Process
Another front in the war against patent infringement
Click here to access the Web site housing this article.
Antibodies, Patents and Freedom to Operate: The Monoclonal Maze
This was originally presented at the IBC Life Sciences 4th Annual Antibody Therapeutics Conference in San Diego, CA December 12-14, 2006.
Appeals Court Calls LeapFrog's Toy Patent "Obvious"
Appendix to Living In A Post-KSR World
Are You Free to Operate? Follow-On Biologics Require Legal Maneuvers
Click here to access the Web site housing this article.
Automatic Inventions: When Machines Help Humans to Invent - Who is the Inventor?
This paper was presented in conjunction with The Fifth Annual Richard C. Sughrue Symposium on Intellectual Property Law and Policy at the University of Akron School of Law and and republished in The Computer & Internet Lawyer, Volume 21/Number 1, January 2004.
Battle Over Patent Rules Will Rage On
Biotech Collaborations and Maximizing Patent Protection: Two Hypotheticals
BlackBerry Patent Dispute Is Settled
Click here to access the Web site housing this article.
BlackBerry patent settlement frees RIM to head off rivals
Click here to access the Web site housing this article.
BlackBerry playing "Russian roulette?"
Click here to access the Web site housing this article.
Brief for Amicus Curiae American Express Company, In Support of Appellants
United States Court of Appeals for the Federal Circuit
Brief of Amici Curiae Interdigital Communications, LLC and Tessera, Inc. In Support of the Respondent
In the Supreme Court of the United States
Brief of Amici Curiae Qualcomm Incorporated and Tessera, Inc. In Support of the Respondent
In the Supreme Court of the United States
Brief of Amicus Curiae Medtronic, Inc. in Support of Petitioner
Brief of Amicus Curiae Vaccinex, Inc. In Support of Respondents
Click here to access the Web site housing this article.
Brief of the Greenville, SC, Kaysville, JT, and Kenton County, KY Public Libraries as AMICI CURIAE in Support of the Appellants
In the Supreme Court of the United States
Business method patents for financial products and services
This article was published as a part of IP Value 2005, Building and enforcing intellectual property value, An international guide for the boardroom. See www.buildingipvalue.com.
Case Law Developments in the United States
This presentation was given by Gillian M. Fenton, Associate General Counsel of Emergent Biosolutions, Inc. and Eric K. Steffe of Sterne, Kessler, Goldstein & Fox at the C5 Conference on Biotech Patenting in Munich, Germany.
Chambers USA - America's Leading Lawyers for Business
Sterne, Kessler, Goldstein & Fox has again been ranked by Chambers & Partners USA as one of America’s leading firms in the area of intellectual property law. Noted by peers for its "integrity, commitment and outstanding disposition to interact with a team," Sterne Kessler was recognized for having "made an impact with its commercially savvy decisions and technological expertise."
Chambers USA - America's Leading Lawyers for Business
Sterne, Kessler, Goldstein & Fox has been ranked for the fourth year in a row by Chambers & Partners USA as one of America’s leading firms in the area of intellectual property law. Noted for being "marvelous with general counseling. It is well thought of here and has a lot of good people."
Chambers USA - America's Leading Lawyers for Business (2006)
Sterne, Kessler, Goldstein & Fox has been ranked for the third year in a row by Chambers & Partners USA as one of America’s leading firms in the area of intellectual property law. Noted for being "committed to working closely with its clients' business, legal and scientific personnel," Sterne Kessler was "renowned for their patent procurement work".
Chambers USA - America's Leading Lawyers for Business (2008)
Changes Afoot in U.S. Patent Law
Rob Sterne is quoted in the article, Changes Afoot in U.S. Patent Law. Rob is one of several expert sources and his photo is included in the gallery at the end of the story.
Changes to the Practice for Handling Patent Applications Filed Without the Appropriate Fees
Click here to access the Web site housing this article.
Child's Play
Click here for article
Comments in Reply to the Notice of Proposed Rulemaking Entitled "Changes to Representation of Others before the United States Patent and Trademark Office"
Click here to access the Web site housing this article.
Comments In Reply To the Notice of Proposed Rulemaking Entitled "Revision of Patent Term Ext. and Patent Term Adj. Provisions Related to Decisions by the Board of Patent Appeals and Interferences"
Click here to access the Web site housing this article.
Comments In Reply To the Notice of Proposed Rulemaking Regarding Changes to Implement the Patent Business Goals
Click here to access the Web site housing this article.
Comments in Reply To the Notice of Proposed Rulemaking Regarding Elimination of Continued Prosecution Application Practice as to Utility and Plant Patent Applications
Click here to access the Web site housing this article.
Comments in Reply To the Notice of Proposed Rulemaking Regarding Rules to Implement Optional Inter Partes Reexamination Proceedings
Click here to access the Web site housing this article.
Computer-Related Patent Law, Strategy and Trends - Release 1.8
Congress Should Not Tread on Court's Resolution of Trademark Disputes
Courts, Not Congress Should Resolve Trademark Disputes
Critique and Consequences of the Supreme Court's Decision in Holmes v. Vornado
This article was published in connection with the 2002 Sedona Conference on Patent Litigation, November 7-8, 2002, Sedona, Arizona and republished in The Journal of Appellate Practice and Process, Volume 5/Number 2, Fall 2003.
D.C. Team Gets to the Root of the Problem
Design Patents and Trade Dress Protection: Are the Two Mutually Exclusive?
Design Patents and Trade Dress Protection: Are the Two Mutually Exclusive? (Japanese language version)
This article was originally published in English in the Journal of the Patent and Trademark Office Society, October, 2005.
Directors at Risk of Personal Liability for Intellectual Property Assets
Directors' Responsibility for Intellectual Property in U.S. Corporations
Distinction with a Difference
Jorge Goldstein is featured in this article about Rainmaking.
Downstream Hatch-Waxman: Unforseen IP Ramifications
Ms. Durkin and Ms. Alcorn authored a Guest Column for IP Law Bulletin.
Drug Discovery Tools and the Clinical Research Exemption from Patent Infringement
Drug Labeling Patents: A New Line of Defense for Protecting Old Drugs?
Drug Name Dilemma
Click here to view .pdf of this article.
eBay Inc. and Half.com, Inc. v. MercExchange, LLC
Brief of Amici Curiae Qualcomm Incorporated and Tessera, Inc. in Support of Respondent
Edward H. Phillips v. AWH Corporation
DEFENDANTS-CROSS APPELLANTS' ADDITIONAL BRIEF FOR REHEARING EN BANC
Elimination of the Best Mode Requirement: Throwing the Baby Out with the Bathwater?
EU Ban Opens E-Waste Market
Click here to access the Web site housing this article.
EU Restarts Patent Directive Process
Click here to access the Web site housing this article.
European Commission Refuses Request for CIID Rewrite
Click here to access the Web site housing this article.
Everything Clean is Green Again
Exploring Nanotechnology at Sterne, Kessler, Goldstein & Fox
Express Route
Click here to access the Web site housing this article.
Expressed Sequence Tags: Any Prior Art Effect?
Federal Circuit Holds that Importing Data is Not Patent Infringement
Federal Circuit Weighs Limits on Business Methods
Firm Solves Patent Disputes in Creative Ways
Click here to view this article.
FLU CONFERENCE COVERAGE: Virus Ownership Claims Could Disrupt Flu Vaccine System
Click here for article.
Former Student Associate Hits Top at Sterne Kessler
H.R. 2795, Patent Act of 2005
Click here to access the Web site housing this article.
Harvesting Inventions - Approaches For Identifying and Selecting Inventions to Patent
High Court Case Could Imperil Pending Patents
Click here to access the Web site housing this article.
High Court Ruling Shakes Up Obviousness Test
Hot Topics in US Patent Practice
How a Chief Intellectual Property Officer Can Strengthen Your M&A Activity
How I Got a Job: Brian Baxter - Legal Assistant at Sterne, Kessler, Goldstein & Fox
Click here to access the Web site housing this article.
How to Identify the Single Tiles of the Inequitable Conduct Mosaic
Mr. Cornwell participated in a panel entitled Fraud & Inequitable Conduct at the USPTO: Trademark & Patent Perspectives moderated by David Ruschke of Medtronic Vascular.
As a part of the program, Mr. Cornwell presented "Defendant's Best Practices - Identifying Inequitable Conduct in File Histories (including Patent Inequitable Conduct Primer)" See the link above.
How to Take Advantage of Business Method Patents
Human Gene Patents
This article is posted with the kind permission of the Journal of Academic Medicine.
Implied Threats Suffice In Patent Disputes Says Court
In re Bilski
Mr. Perry presented on In re Bilski at the Japanense Attorneys Association in Tokyo, Japan. To access the presentation click on the pdf above.
In Re Seagate: We Have Met The Enemy, And He Is Us
Indispensable Tips for IP Savvy VCs
Inequitable Conduct Findings Are on the Rise
Click here to access the Blog entry.
InfoStar: Kelley Martin
quantum.dialog.com/people/infostars
Inside the Minds: IP Legal Strategies
Robert Sterne authored a chapter in this book titled, "The Virtual Chief Intellectual Property Counsel in the Corporate Landscape".
Integrating IP Value Assessment Into Early-Stage M&A Activity
Integrating PTO Proceedings in Litigation Strategy
This paper was prepared for the The 2006 Sedona Conference on Patent Litigation.
Interdisciplinary Nanotechnology Commercialization: The Next Wave - Through the Eyes of a Patent Attorney
Presented in conjunction with the Washington Academy of Sciences Forum - Nanotechnology: An Interdisciplinary Endeavor
Inventor Who Prosecuted Own Patents Loses Appeal
Inventorship Disputes Don't Have to be Costly
The authors look at how you can avoid inventorship disputes and explain how to resolve them when they occur.
IP Boutiques: Surviving and Thriving
Click here to access the Web site housing this article.
IP Issues in Nanotechnology - A View from Around the World
Presented at NSTI Nanotech 2004.
Is Your Career on Track?
Click here to access the Web site housing this article.
KSR International Co. v. Teleflex Inc.: Another Small Issue for Nanotechnology?
KSR International Co., v. Teleflex Inc., et al.
On Tuesday, November 28, 2006, the United States Supreme Court heard oral arguments in KSR. v. Teleflex, Case No. 04-1350, the most important patent case it's heard in 40 years. The case addresses the fundamental patent law question of how much “creativity” in an invention is enough to get a patent.
KSR International Co., v. Teleflex Inc., et al.: Counsel Post-Briefing Audio
Counsel Post-Briefing
KSR v. Teleflex Creates Uncertainty
Launching Patent Licensing for an Emerging Company
This paper was originally presented at the Sixth Annual Seminar on Licensing Intellectual Property on March 16, 2004 held at the University of Dayton School of Law.
Law as a Second Career?
Click here to access the blog.
Leading Lawyers: Eight of the DC Area's Top Life Sciences Attorneys
Leading Lawyers: Legal Times Identifies Fifteen of the D.C. Area's Top IP Attorneys
Left Turns Only - Making Sense of Nanotech IP Strategy
Presented at the International Engineering Consortium, NanoEngineering World Forum in Marlborough, MA.
Let Opposing Forces Gather: Post-grant process could fix questionable patents faster
Limitations on the Doctrine of Equivalents
Living In A Post-KSR World
Click here to access the Appendix.
Madrid Protocol: What is it and How Does it Work?
Mark Fox Evens Joins Sterne, Kessler, Goldstein & Fox
Market Central Launches Intellectual Property Asset Management Program
Master of Studies in Law Program, University of Pittsburgh School of Law
Alumna, Kathryn Beckman is quoted in this brochure. See, "What Our Graduates Are Saying."
Merck KGaA v. Integra: Analysis of the Supreme Court Decision and Its Impact on Bio-Pharma Collaborations
This was presented in conjunction with the LES Annual Meeting in Phoenix, AZ.
Michael Lee Named to Patent Hall of Fame
Microsoft Ordered to Cough Up $1.5B in Patent Case
Click here to access the Web site housing this article.
Monitoring the U.S. Patents of Competitors: The Willfulness Risks to the Innovator
This paper was presented at Practising Law Institute's Ninth Annual Institute for Intellectual Property Law.
More on KSR International Co v Teleflex Inc. - this is a big one
Click here to access the Web site housing this article.
My Technology Lawyer Radio Show: Supreme Court Series
Ken Bass talks with radio host Scott Draughon about the Amicus Brief filed on behalf of Medtronic in MedImmune v. Genentech.
Nano World: Lawyers Key to Nano-Revolution
SKGF noted as a "top IP boutique."
Nanotechnology and the Best Mode
Nanotechnology Intellectual Property Exploitation Strategies
Presented at the International Engineering Consortium, NanoEngineering World Forum in Marlborough, MA.
Nanotechnology IP Licensing: Think Big, But Keep Your Feet on the Ground!
Presented at the Licensing Executives Society 2004 Winter Meeting.
Nanotechnology Patents: What Can Be Learned?
This presentation was given in conjunction with the Nano Science and Technology Institute, Nanotech 2005 program in Anaheim, California.
Nanotechnology: Perspectives on the State of the Art and Intellectual Property
Presented at: Third Annual Hot Topics in Intellectual Property Law, Duke University School of Law.
New Patent Issues Surrounding Therapeutic Antibodies
This was orignially presented at the LSI International Biotechnology Conference 2007 in San Francisco, CA.
New Patent Office Rules Would Pose A Severe Hardship For The Pharmaceutical Industry
New PTO Rules Create Nov. 1 Requirement
New Rules 75, 78 Unfairly Penalize Research Entities
New USPTO Electronic Patent Filing System Goes Live
New Web Site May Smooth Patent Process
Click here to access the Web site housing this article.
Obviousness of Chemical Compounds: The "Lead Compound" Concept - Addendum
Click here to access the Web site housing this article.
Obviousness of Chemical Compounds: The "Lead Compound" Concept
Click here to access the Web site housing this article.
On-Campus Interviews Allow Law Firms to Meet Potential Associates
Click here to access the Web site housing this article.
Open Source's New Weapon: KSR v. Teleflex Ruling
Osram Sylvania Prevails in Inequitable Conduct Case Against Ole Nilssen of the Geo Foundation
Out of the Gate - Nanotechnology Intellectual Property Groundwork
Presented at the International Engineering Consortium, NanoEngineering World Forum in Marlborough, MA.
P&G Case Underscores Trade Dress Challenges
Patent Abuse - Drug companies lobby to stall WTO's new compulsory license provision.
Click here to access the Web site housing this article.
Patent Appeals Board Ditches TSM for Stricter Tests
Patent Board Challenges Federal Circuit to a Duel
Patent Lawyer Discerns Why Gadgets Tick
Posted with the kind permission of Dayton Lawyer, a publication of the University of Dayton School of Law.
Patent Lawyers Sweat as Supreme Court Hears Teleflex
Click here to access the Web site housing this article.
Patent Pollution - Strategies for protecting clean energy technology
Patent Pools as a Solution to the Licensing Problems of Diagnostic Genetics
Patent Prosecution and Joint Ownership of United States Patents
Patent Protection
Click here to access the article.
Patent Reform Bill Lands in House, Senate
Patent Reissue after Eggert: Reclaiming the Ring
Patent Rights From Stem Cell Research Funded By Proposition 71
This poster was presented at the 3rd Annual Meeting of the International Society for Stem Cell Research June 23-25, 2005 in San Francisco, CA.
Patent Wisdom - A CEPS alumnus outlines the potential and pitfalls of patenting
Click here to access the Web site housing this article.
Patenting Antibodies: The Past, Present and Future
This was presented in conjunction with the IBC Life Sciences 3rd Annual Antibody Therapeutics Conference in San Diego, CA.
Patenting Software and Business Method Inventions in the U.S. and Europe
Patenting the Tools of Drug Discovery
PatentRatings, LLC Names Top Patent Firms for 2003
Sterne, Kessler, Goldstein & Fox has been recognized by PatentRatings, LLC in its annual patent quality survey for 2003. The survey's goal is to objectively assess which firms create the most value for their clients.
Patents That Cover Industry Standards - Companies risk losing patents by failing to disclose
Reproduced by permission. All rights reserved. This information or any portion thereof may not be copied or disseminated in any form or by any means or stored in an electronic database or retrieval system without the express written consent of the American Bar Association.
Patents: What Are They Worth? Sarbanes-Oxley Changes The Way Companies Value IP
Pedal to the Metal - Supreme Court adopts new standard on patent litigation
Click here to access the Web site housing this article.
Podcast #6 -- Patent Law at the Supreme Court
Click here to access the podcast.
Possible Divisional Application Filings By November 1, 2007
Practice Tips: Press Your Advantage
Preliminary Injunction Prevents Patent Office from Implementing Controversial New Rules
Preparing and Prosecuting a Patent that Holds Up in Litigation
This article was presented at PLI's Patent Litigation 2006.
Protecting innovation in biotechnology startups
Click here to access the Web site housing this article.
Published Federal Circuit Cases on Doctrine of Equivalents 2000-2001
Q&A With Sterne Kessler's David K.S. Cornwell
Reading the Blackberry Tea Leaves
Real World Impacts of Reexamination Practice and Procedure
Reexamination Practice with Concurrent District Court Patent Litigation
Researchers watch virus-sharing talks with trepidation, fearing science may suffer
Click here to access the Web site housing this article.
Revisiting Patent Rights In Taiwan: 2004
RIM wins Blackberry reprieve
Click here to access the Web site housing this article.
RIM, NTP urged to settle dispute
Click here to access the Web site housing this article.
Ringling Kin Hits a Roadblock
www.heraldtribune.com
Robert Greene Sterne Named to Boys Scouts NCAC Executive Board
Robert Greene Sterne Retained to Enforce Intellectual Property Rights in RTL Silicon Virtual Prototype Technology for Tera Systems
Click here to access the Web site housing this article.
Robert Greene Sterne Selected as "A Best Lawyer in America"
Scientigo has Assembled a World Class Team of IP Professionals
SKGF Client Parkervision Ranked As Top Ten Innovator By The Patent Board
SKGF Nanotube Patent Study - 2004
This presentation was given in conjunction with the Nano Science and Technology Institute, Nanotech 2005 program in Anaheim, California.
Sky Radio Interview: Business & Technology
In this interview airing on Sky Radio on Delta Airlines, US Airways, Northwest and United Airlines, Robert Sterne responds to the question, "Who Owns Data?"
Snapshot Patenting -- A Practical Alternative to Protecting Innovation, Part 1
This article was distributed by Cutter Consortium.
Snapshot Patenting -- A Practical Alternative to Protecting Innovation, Part 2
This article was distributed by Cutter Consortium.
Stem Cells - Patent Pools to the Rescue?
Stem Cells- California's Proposition 71
This is the first article in a series on developments in stem cell patenting.
Stem Cells- The Patent Landscape
Stem Cells- The Patent Landscape
This poster was presented at the 3rd Annual Meeting of the International Society for Stem Cell Research June 23-25, 2005 in San Francisco, CA.
Stem Cells- The Patent Landscape
Sterne Kessler Law Librarian Receives International Recognition
Sterne Kessler Named First IP Benefactor at The George Washington University Law School
Sterne Kessler Renews Intellectual Property Law Scholarship
Click here to access the Web site housing this article.
Sterne Kessler Sees Nanotech as Next IP Frontier
Sterne Kessler Web Site Uses Flash and Content to Stand Out
Click here to access the Web site housing this article.
Sterne Kessler Welcomes Two George Mason Scholarship Recipients As Summer Associates
Sterne Talks about RIM/NTP with Bloomberg Radio
Sterne, Kessler, Goldstein & Fox Announces Arrival of New Associates and Technical Specialists
Sterne, Kessler, Goldstein & Fox Announces Balanced Lifestyle Initiatives
Sterne, Kessler, Goldstein & Fox Announces Election of New Directors
Sterne, Kessler, Goldstein & Fox Announces Election of New Directors
Sterne, Kessler, Goldstein & Fox Announces Four New Associates
Sterne, Kessler, Goldstein & Fox Announces Return of Senior Attorney
Sterne, Kessler, Goldstein & Fox Attorneys Named Certified Licensing Professionals
Sterne, Kessler, Goldstein & Fox Attorneys Named to "Washington DC Super Lawyers"
Sterne, Kessler, Goldstein & Fox Establishes First CleanTechSM Industry Group
Sterne, Kessler, Goldstein & Fox Helps Solve Inventor Disputes
Sterne, Kessler, Goldstein & Fox Launches Nanotechnology Practice Group
Sterne, Kessler, Goldstein & Fox Named "Go-To Law Firm"™
Sterne, Kessler, Goldstein & Fox Named to the Legal 500
Sterne, Kessler, Goldstein & Fox Ranked Among America's Leading Law Firms for Sixth Consecutive Year
Sterne, Kessler, Goldstein & Fox Ranked as One of America's Leading Law Firms
Sterne, Kessler, Goldstein & Fox Snags Trial Attorney
Sterne, Kessler, Goldstein & Fox Welcomes 2008 Summer Associates
Sterne, Kessler, Goldstein & Fox Welcomes A Dozen New Associates and an Of Counsel
Sterne, Kessler, Goldstein & Fox Welcomes Trio of Technical Specialists and New Patent Agent
Sterne, Kessler, Goldstein & Fox Welcomes Two Litigation Associates
Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice
To access the audio portion of this webinar:
Call 1-888-266-2081 (toll free, US & Canada) or 703-925-2533 (international).
The access code for both is: 1140991.
The audio feature will be available until December 18, 2007.
Successful Transitions: The New Managing Partner's First Days
Supreme Court Adopts New Standard on Patent Litigation
Click here to access the Web site housing this article.
Supreme Court Case: KSR v. Teleflex
Supreme Court Hears Most Significant Patent Case in 40 Years: KSR v. Teleflex
Click here to access the Web site housing this multimedia release.
Supreme Court hears patent challenge in case involving lucrative drug patent
Kenneth C. Bass, III comments on MedImmune v. Genentech. Choose Track 3.
Supreme Court Limits Patent Suits
Click here for the web site housing this article.
Supreme Court loosens patent 'obviousness' test
Click here to access the Web site housing this article.
Supreme Court Rules in KSR v. Teleflex
Click here for the Opinion
Supreme Court showdown on obviousness
Click here to view this article.
Supreme Court Weakens Patent Rights
Click here for the web site housing this article.
Targepeutics, Inc. Announces Patent License Agreement With National Institutes of Health
Click here to access the Web site housing this article.
Technology Companies Win as High Court Limits Patents
Click here to access the Web site housing this article.
Testimonial for Greenfield Belser
Click here to access the Web site housing this article.
Testimony of Eric K. Steffe Regarding a Bill Proposed by Mr. Smith Amending 35 U.S.C. Sections 102(f) and 103(c) (CREATE)
Eric Steffe testified before the U.S. House Judiciary Committee Subcommittee on Courts, the Internet and Intellectual Property on June 10, 2003.
The American Inventors Protection Act: The End of the Line for In re Wertheim?
The BlackBerry Patent Saga - - How Will it End?
The BPAI Returns to Graham v. John Deere
The Common-Interest Doctrine and Intellectual Property Due Diligence
The Expansion of Statutory Subject Matter Under the 1952 Patent Act
This paper was presented in conjunction with The Fifth Annual Richard C. Sughrue Symposium on Intellectual Property Law and Policy at the University of Akron School of Law.
The Impact of Patent Reform on Nanotechnology: File Early and File Often
This poster was presented at the Nanotech 2006 Conference in Boston, May 8-9, 2006.
The KSR Decision - What Does it Really Mean?
The Medicare Modernization Act of 2003: The Effect on Entry of Generic Drugs into the Marketplace
The New Profit Center: Ideas
Click here to access the Web site housing this article.
The Patent Infringement Land Grab
The Patent Process - Current Rules vs Proposed Rule Changes
This chart gives a visual overview of the current patent examination process and how that process may change if proposed rule changes are enacted.
The Patenting Tools of Drug Discovery and Development
The Perfect Storm
Recent rulings by the Supreme Court, rule changes in the United States Patent and Trademark Office, and patent reform legislation are having a significant impact on patent law. To help you prepare, we offer the following resources:
The Power of Prior Art: Get a handle on this concept to avoid legal problems and gain a competitive edge
Click here to access the Web site housing this article.
The Sedona Conference: Willfulness Opinion of Counsel Questionnaire Survey Results
This survey was taken at The Sedona Conference on Patent Litigation on November 6, 2003. It was published in The Sedona Conference Journal, Fall 2004, Volume 5.
The Supreme Court's Renewed Interest in IP
The U.S. Patent Landscape for Electronics Companies
The Write Stuff
Michael Q. Lee received Honorable Mention when IP Law & Business named the first entrants to its Patent Hall of Fame.
The Written Description Requirement
This paper was presented in conjunction with The Fifth Annual Richard C. Sughrue Symposium on Intellectual Property Law and Policy at the University of Akron School of Law.
Theodore Wood Named to University of Dayton School of Law Alumni Board of Trustees
Thorny times for Blackberry - Judge agrees patent was violated but delays injunction
Click here to access the Web site housing this article.
TiVo's Time Warp Patent Claims Valid: PTO
Tracy-Gene G. Durkin Named President of Women's Bar Association in the District
Trademark Confusion in the Pharmaceutical Industry
Can you imagine this scenario? Your company has just expended a great deal of time and money to bring the latest wonder drug to the market place. You've got high expectations and an agressive marketing plan in place. The only obstacle impeding launch of the drug - the Food and Drug Administration (FDA) has refused the trademark proposed in your drug application. A potential disaster to say the least!
Trends in Patent Laws are All Around Us
U.S. Patent Reform and the Future of Nanotechnology
Click here to view a copy of this article.
U.S. Supreme Court Report: MedImmune v. Genentech
U.S. Supreme Court Urges a Less Rigid Approach in Assessing the Obviousness of Inventions
Reference page 7 of the attached newsletter.
Universities, Hospitals Join Patent Litigation Bonanza
US Patent Reform - Will 2006 be different than 2005?
Use of Intellectual Property in Launching an Internet Business
Use of Intellectual Property in Launching an Internet Business in a Hostile Space
USPTO Bio/Chem Pharma Customer Partnership Meeting
USPTO Patent Examination Reform and Proposed Rule Changes
USPTO Proposed Rule Changes - Impact on Small Business
USPTO Round Table on Equity of Inter Partes Reexamination Proceedings: Transcript and Comments
Click here to access the Web site housing the introductory information about the hearing.
USPTO Strategic Plan (2007-2012) Public Forum Report
Viagra Natural
Maca, a plant grown in the Andean highlands, is believed to boost male potency. The Quechua Indians cultivate it; a New Jersey company owns the patent on it. The Americans call the work that led to the patent bioprospecting. Others say it's stealing.
VOIP Regulation: The Time Has Come
Click here to access the Web site housing this article.
What Did the Board Know?
With all due respect for privilege, boards of directors demand the full story of corporate IP.
What Triggers Willful Patent Infringement: Actual Notice or Actual Knowledge?
What You Need to Know about the Proposed USPTO Rule Changes and Other Reform Initiatives
What You Need to Know About the Proposed USPTO Rule Changes and Other Reform Initiatives
Dr. Cimbala presented this material during the Licensing Executive Society meeting on May 3, 2006.
When It's Time To Pay Up: Law Firms Need Software To Help Organize the Collection Process
Sterne Kessler's CFO Tom Annick is quoted in this article regarding collections software.
Why Directors Must Take Responsibility for Intellectual Property
Why IP is Essential in All Stages of the M&A Process
Willful Patent Infringement as a Barrier to Dissemination of Patent Information
This aritcle is published in connection
With Planning and Perseverance, Broad Patent Coverage for Biotechnology Inventions Can Be Obtained in the United States
This article is reprinted from the Japanese language "Life Science Report No. 7, 2006, pp. 508-518, Tokyo Medical and Dental University, Intellectual Property Division"
Your Firm in Five Years: Taking Charge of Long-Term Strategic Planning
14th European Forum on Biotech Patenting
Mr. Steffe will be speaking on recent biotech patent upheavals and developments in the United States. Topics include:
2007 LES Winter Meeting
Please join Dr. Goldstein for this workshop "2D Inventorship Disputes in Scientific Collaborations: How They Arise, How to Prevent Them and How to Resolve Them"
2007 Mid-Atlantic Bio
Dr. Jorge Goldstein will moderate a panel discussing, "A Pragmatic Overview of Cases, Decisions, and Legislation which Will Affect the Biotech Industry Moving Forward."
Permanent injunctions are harder to get, licensee challenges are easier to lodge, non-obviousness is harder to prove, it is harder to avoid the clinical research exemption, Congress is discussing uncertain "patent reform," and the PTO… just limited the numbers of claims and continuations that you have the right to file!
What is a patent holder to do?2007 Military Communications Conference
Dr. Sharifi will present, "Bifurcation Control in PRMA Joint Voice-Data System Using Multiple Transmission Power Levels."
22nd Annual Intellectual Property Law Conference
Mr. Sterne will participate on a panel discussing, "Re-Writing Patent Law: the Supreme Court's Decision in MedImmune, KSR and Microsoft."
25th Annual Institute on Computer & Internet Law
The presentation is entitled, "Patent Assets: Offensive & Defensive Strategies." It will cover -
2nd Patent Strategies: Protecting IP and Maximizing Revenue in Today's Challenging Marketplace
Please join Dr. Cimbala for her panel discussion, "What You Need to Know About the Proposed USPTO Changes and Other Reform Changes."
4th Annual Meeting of the International Society for Stem Cell Research (ISSCR)
Join Dr. Esmond as he presents his poster on stem cell patenting entitled, "Stem Cells - The Patent Landscape" at the Metro Toronto Convention Centre, June 29 - July 1, 2006.
5th National Conference on Pharma/Biotech IP Due Diligence
Dr. Del Buono will participate on a panel entitled, "Evaluating the Scope, Validity and Enforceability of the Target's Patents."
6th Advanced Forum on Biotech Patents
Dr. Cimbala will speak on "Preparing for Patent Reform."
75th Anniversary Celebration of Phi Iota Alpha
On Saturday, July 28, Jorge Goldstein will be the keynote speaker at the 75th anniversary celebration of Phi Iota Alpha in New York. Phi Iota is the most prominent and oldest hispanic fraternity in the U.S and Dr. Goldstein is an alumnus, having joined it during his undergraduate years at Rensselaer Polytechnic.
7th Advanced Forum on Biotech Patents
Please join Dr. Cimbala for her panel discussion, "Navigating the Murky Waters of Patent Reform in the Biotech Industry."
KSR International Co. v. Teleflex Inc.: Where Do We Stand Five Months Out?
In KSR International Co. v. Teleflex, Inc., the U.S. Supreme Court handed down perhaps the most important patent case in 40 years. Five months after this decision was handed down, where exactly does the patent community stand?
Join Teleflex’s counsel for an overview and detailed analysis of the "obviousness doctrine" in the wake of the monumental KSR decision. The team will discuss recent actions by the United States Patent and Trademark Office's Board of Patent Appeals and Interferences (BPAI) and the Central Reexamination Unit. The team will closely examine the most relevant portions of the "post-KSR" rulings issued by the Court of Appeals for the Federal Circuit and U.S. District Courts.
The team will also explore the current landscape for practitioners focusing on how recent ruling are affecting the day-to-day work of preparing and prosecuting patents. Additionally, the panel will discuss how "obviousness" is coming into play in the litigation arena.
A Guide to Appellate Practice in Virginia
Kenneth Bass will moderate this seminar intended to blend the observations of sitting Supreme Court of Virginia justices and Court of Appeals of Virginia judges with the insights of practitioners who have vast experience in handing appellate cases.
A TeleBriefing on Phillips v. AWH Corporation
The Court of Appeals for the Federal Circuit's decision in Phillips v. AWH Corporation raises significant questions about the future of patent litigation. In this one-hour TeleBriefing, seasoned patent litigators, Kenneth Bass of Sterne Kessler Goldstein & Fox PLLC and Edward Manzo of Cook, Alex, McFarron, Manzo, Cummings & Mehler, Ltd., will discuss, analyze and provide practical insight on issues, such as: Are dictionaries dead in patent litigation? What about testimony from technical experts? Should the court accord deference to trial court claim rulings?
ACI's 9th Advanced Forum on Biotech Patents
Mr. Steffe will present, "Prosecuting Antibody Claims - Tactics for Addressing the Many Challenges."
ACI's 9th Advanced Forum on Biotech Patents
Dr. Cimbala will present, "Where Are We Now? Update on Patent Reform at the USPTO."
ACI's Pharma/Biotech Patent Claim Drafting & Prosecution
Dr. Cimbala will be presenting "Bracing for the Impact of Patent Reform on Patent Portfolio Management in the Life Sciences Industries."
AIPLA 2007 Annual Meeting
Mr. Cornwell will participate in a panel entitled Fraud & Inequitable Conduct at the USPTO: Trademark & Patent Perspectives moderated by David Ruschke of Medtronic Vascular.
As a part of the program, Mr. Cornwell will present "Defendant's Best Practices - Identifying Inequitable Conduct in File Histories (including Patent Inequitable Conduct Primer)"
AIPLA 28th Mid-Winter Institute
Ms. Durkin will moderate the Industrial Design Committee meeting on Friday afternoon. The meeting features a panel discussion of issues unique to resolving design patent infringement disputes.
AIPLA Spring Meeting
Ms. Durkin will be chairing the meeting of the Industrial Designs Committee of AIPLA. The meeting is in Salon 10, Mezzanine Level.
AIPLA'S "Women In IP" Cross-Country Networking Dinner
Tracy-Gene Durkin will be speaking about the Study by the Women's Bar of DC on the advancement and retention of women in the legal profession. She will also speak about her experience as president of the Women's Bar Association of DC and as a female practice group leader in an IP firm.
AIPLA's 2007 Advanced Patent Litigation Seminar
Mr. Messinger is will participate on a panel discussing, "Alternative Routes: Reexamination Proceedings During a Lawsuit. Specifically, Mr. Messinger will present on the patent owner's perspective.
American Conferece Institute's 8th Advanced Forum on Biotech Patents
Dr. Cimbala will participate on a panel "Navigating the Murky Waters of Patent Reform in the Biotech Industry." Specifically, she will discuss proposed changes to the USPTO rules and restriction practice.
Antibody Therapeutics: Strategic Advances in Therapeutic Antibody Pipeline
Dr. Ebersole and Mr. Shea will present, "Patent Law on Antibodies: Understanding Its History and Evolution."
Attorney of the Year "Good Scout" Award Luncheon
Avian Flu Pandemic: Mitigating Risks to Your Business
Please join Ms. Durkin as she moderates this panel at the Association of Legal Administrators Town Hall Meeting. A light breakfast will be served at 8:00am. For more information please visit www.alacapchap.org
BIO 2005 Annual International Convention
Visit us at Exhibit Booth 2737, June 20-22.
BIO IPCC Meeting
Mr. Steffe will moderate a panel discussion on recent case law.
Biojudiciary Project Open House
Dr. Ellison will give a presentation on the Patent Act of 2005 and its impact on biotechnology.
Careers in Patent Law for Engineers & Scientists
Mr. Ray will present, "What is intellectual property and what do engineers need to know about it?" The basics of patent, trademark, copyright and trade secret law will be covered during this discussion, with primary focus on patents.
CBI’s Summit on Novel Drug Delivery Strategies
Mr. McCabe will be presenting on the topic, "Strategic Evaluation of Drug Delivery Patent Litigation."
Challenges and Opportunities for IP Boutiques
Dr. Goldstein will participate in a panel examining:
Changing Horizons: AUTM 2008 Annual Meeting
Mr. Sterne will speak on, "KSR v. Teleflex: It's Implications for Technology Transfer Professionals."
Cleantech 2007
Mr. Messinger will present in poster form, "Indispensible Tips for IP Savvy VC's."
Computer and Cyberspace Law Seminar
Please join Ted Wood and Rob Sterne as they present at this full day conference on significant developments in Computer and Cyberspace Law from the patent perspective. The event will be held in the Joseph E. Keller Hall, exact times will be posted as they become available.
Conference on Biodefense Vaccines, Therapeutics and Diagnostics
Dr. Goldstein will direct a workshop entitled, "Intellectual Property Issues in Vaccines, Therapeutics and Diagnostics Development."
Creating Stem Cells by Research Cloning: Scientific, Ethical, Legal & Policy Challenges
Ms. Kim will participate in a break-out session addressing intellectual property issues.
DeVos Medical Ethics Colloquy
Dr. Goldstein will speak on "Gene Ownership & Patents."
Drafting & Negotiating Patent License Agreements 2007 - Advanced Strategies and Techniques
During this one-day workshop, Mr. Lee will discuss, "Avoiding Common Mistakes in License Agreement Drafting." Topics include:
Drafting & Negotiating Patent License Agreements 2007 - Advanced Strategies and Techniques
During this one-day workshop, Mr. Shea will discuss, "Licensing After MedImmune, E-Bay and Microsoft.
Duke Career Week 2007
Please come visit Mike Messinger at Duke Career Week! He will be a "Career-field Panel Participant" for Law Firms. For more information please visit Duke Career Week
Duke Law's Intellectual Property and Cyberlaw Society Hot Topics Symposium
Messrs. Featherstone and Specht will present, "Nanotechnology: State of the Art and How It's Being Patented."
Eurolegal's Biotech Patenting Conference
Dr. Esmond will co-chair a half-day workshop entitled, "Advanced Drafting Techniques for the New Generation of Biotech Patents."
Evaluating and Maintaining Brand Value
Please join Ms. Durkin at the 2006 Ocean Tomo Patent Auction in New York City, October 25-26, 2006.
Farm Equipment Manufacturers Association Spring Management Clinic
Mr. Rygiel will be speaking on the topic of effective IP strategies in the global economy.
Food Marketing Institute Legal Conference
Ms. Durkin, along with Melissa Sellers, General Counsel at Phillips Foods and Seafood Restaurants, will present, "Creating and Implementing an Effective Corporate Intellectual Property Program."
Generics & Patent Life Cycle Management- Strategies in the Pharmaceutical Industry 2004
Dr. Esmond and Dr. Millonig will present "U.S. Rules & Regulations - Current Issues". This presentation will cover:
GLG Law Council - NTP/RIM Event
At this event, Rob Sterne will be helping senior analysts and portfolio managers with some of Wall Street's premier technology-focused hedge and mutual funds who seek to better understand the legal background of the NTP v. RIM case.
Global Follow-On Biologics: Strategies for an Explosive New Biotech Market
At the IBC Life Sciences 3rd International Conference on Global Follow-On Biologics: Business, Regulatory and Scientific Strategies for an Explosive New Biotech Market, Dr. Del Buono will speak on "Analysis of Innovator Patents and Determining Freedom to Operate".
Goodwin Proctor's 2nd Annual Directors Forum
How to Maximize the Value of Your Business For Sale
Designed for C-level executives, general counsel, investors, executive officers and board members.
How to Write for Internet Search Engines
Search Engine Visibility is the next step in marketing and public relations. Over 550 million searches on the web are performed everyday. If it is true that knowledge is the key to succes, then knowing how to use search properly can help you maximize your marketing and PR abilities - and the placement of your company and organization in search engines. Our two experts will talk about how maximize your results with your current communication - press releases, web sites, etc., teach the difference between natural search and paid for search, and answer your questions about how search engines work.
Intellectual Property Considerations in Strategic Alliances
Join the IP Law Forum of the Women's Bar Association of DC in a Luncheon Presentation.
Intellectual Property Licensing CLE Seminar
Mr. Wood will present, "IP Licensing, Avoiding the Pitfalls."
Intellectual Property Owners (IPO) Annual Meeting
Ms. Durkin will be speaking on "Effective Design Protection and Enforcement". She will take a practical look at protecting product design in the U.S. using copyright, trade dress and design patents.
Intellectual Property Workshop: Protecting Your Crown Jewels
Mark F. Evens will participate on a panel covering many aspects of intellectual property protection:
Intellectual Property: Protecting Your Ideas
Messrs. Messinger and Doyle will lecture for the Entrepreneurship class at the University of Maryland.
International Fuel Ethanol Workshop & Expo
Mr. Jackman will be co-presenting with Timothy Linkkila, Mascoma Corporation, on the topic "Leveraging IP for Cleantech Innovators."
International Symposium on Patenting, Regulating and Commercializing Stem Cells
Please join Dr. Esmond as he presents, "Sucessfully Patenting Stem Cells: Key Insights in How to Obtain Patents from the UK Patent Office, EPO and USPTO."
International Trademark Association 127th Annual Meeting: Trade Dress - A U.S. Perspective
Ms. Durkin will be leading a roundtable discussion at INTA's Annual Meeting on "Trade Dress - A U.S. Perspective."
IP Business Congress: The Annual Event for Global IP Leaders
IP Law as an Alternative Career for Students Pursuing Technical Degrees
KSR International v. Teleflex: Discover How the Court's Ruling Will Affect the Patent Landscape
To join the webcast, please click here
Legal Marketing Association - Capital Chapter May Program
Ms. Mangan will join a panel discussing, "Managing Relationships with PR Firms to Achieve Success."
LES 2007 Annual Meeting
Dr. Cimbala and Mr. Lee will present, "Hot Topic 1 - The New USPTO Rules Limiting Claims and Continuations - What You Need to Know and Actions You Need to Take."
The new US Patent Office rules limiting claims and continuations go into effect on November 1, 2007. These rule changes will significantly impact both the ability to patent, and the process for patenting, inventions in the United States. This workshop will cover the scope and content of the new rule changes, as well as letting you know what you need to do now for your pending applications, and how you'll need to adjust your strategy for patenting inventions in the United States. This workshop will also look at the interrelation of the claims and continuation rules with the proposed rulemarkings for alternative claims practice and change to BPAI procedures.
LES 2007 Annual Meeting
Messrs. Lee and Bass will join Stephen Chow of Burns & Levinson and Daniel Robbins of the Motion Picture Association of America to discuss, "In re Nuijten and its Impact on the Software, Internet and E-Commerce Industries."
This workshop will analyze the practice implications surrounding the Federal Circuit's expected decision in In re Nuijten, which puts at issue whether an electrical signal is statutory subject matter as a "composition of matter." The claim at issue is particularly useful for Digital Rights Management, but the issue underlies whether information, including software, that is distributed electronically is patentable in that form. In the USPTO's 1995 Examination Guidelines for Computer- Related Inventions, computer programs embedded in electrical signals have been considered patentable. However, in recent years, the Patent Office has retreated from that policy. Whether information in an electromagnetic signal consititutes "matter" is also an issue in other contexts. The panel will synthesize the impact of the expected decisions in AT&T and In re Nuijten on the software, internet and e-commerce industries.
Licensing Executives Society 2006 Annual Meeting
Please join Mr. Lee as he moderates the High Technology Sector Mini-Plenary. Mr. Lee will also be speaking on "How Reform is Affecting the Ability to Protect Inventions."
Licensing Executives Society 2006 Annual Meeting
Please join Mr. Shea as he moderates the panel presentation, "Global Licensing: A Comparative Analysis". In this seminar, a hypothetical term sheet for a collaboration and development agreement between a biotech company and a pharma company involving stem cell technology will be analyzed from the perspective of an international panel of licensing professionals to highlight potential legal and practical issues that are treated differently in the various regions.
Licensing Executives Society Winter Meeting
Mr. Lee will lead a roundtable discussion on "Patenting Software and Business Method Inventions in the U.S. and Europe."
Munich Vaccine Forum 2007
Please join Betsy Haanes for her presentation, Vaccine development in the international marketplace: Intellectual property challenges and rewards in "going offshore".
NALP's 2008 Diversity Summit
This conference will provide a forum for a robust exchange of information about the current challenges and innovations surrounding the issue of diversity in the legal employment arena with a focus on:
NanoEngineering World Summit
Messrs. Featherstone and Specht will present, "Nanotechnology Patents: Leveraging Patents to Stimulate Technology and Business Development."
Nanotechnology Customer Partnership Meeting
Mr. Featherstone will moderate a panel of industry experts to discuss their views on the nanotechnology industry and nanotechnology patents.
National Bar Association Commercial Law Section's 20th Annual Corporate Counsel Conference
Dr. Ellison will moderate a panel as it discusses, "Managing Your Intellectual Property in a Changing, Perhaps Flatter, World."
National Institutes of Health Graduate Partnerships Program
Dr. Goldstein will teach a seminar on Patent Litigation.
National Nano Engineering Conference
Mr. Featherstone will lead a panel discussing, "Strategies for Optimizing IP Coverage Under the New PTO Rules." Panelists include:
No Man's Land: Where Growing Companies Fail
This is a C-level executive seminar hosted by Sterne, Kessler, Goldstein & Fox. Doug Tatum will identify a common set of challenges that limit the ability of emerging-growth and middle-market companies to succeed.
Non-Invasive Imaging in Drug Discovery Conference
Mr. Steffe will speak on "Non-invasive Imaging Patents and Freedom to Operate."
Northwest Regional Meeting of LES
Dr. Goldstein will present, "Patent Pools as a Solution to Licensing Problems in Diagnostic Genetics."
NSTI Nanotech 2006
Dr. Jeffrey Mills, along with Dr. David Needham of Duke University, will present, "Temperature-Triggered Nanotechnology for Chemotheraphy: Rapid Release From Lysolipid Temperature-Sensitive Liposomes."
Patent "Trolls" and Patent Property Rights
Mr. Sterne will moderate a panel on "Operating in Today's Patent Assertion Environment." Discussion will cover:
Patent Interferences Rules & Practice Conference
Mr. Bass will present, "Challenge in the U.S. Supreme Court to the Law of Obviousness: KSR International v. Teleflex.
Patent Law Reform: Where is it Going and When will it Get There?
Join the Intellectual Property Law Forum of the Women's Bar Association of the District of Columbia for a luncheon presentation.
Patent Litigation in China and Japan
Mr. McCabe will moderate the panel discussing the basics and newest developments in Japanese and Chinese patent litigation. Included on the panel are Judge Yasuhiro Ichiba who presides over patent cases in Tokyo, Japan, and attorney Xiaoguang Cui who advocates on behalf of Chinese and foreign clients in patent litigation matters in Beijing.
Patent Pools Workshop
Dr. Goldstein will be a commentator at this Patent Pools Workshop, June 8 - 9, 2006 at the Centre for IP Rights in Leuven, Belgium.
Patent Portfolio Management for the Biotech and Pharmaceutical Industries
More information will be posted as it becomes available. In the meantime, please visit www.americanconference.com
Product Development and Management Association Carolinas Meeting
Ms. Durkin will present, "Intellectual Property: The Top 10 Things You Need to be Aware of When Developing and Bringing a New Product to Market."
Protection of Intellectual Property Rights
In this conference sponsored by The Center for International Legal Studies, Ms. Kim will be participating on a panel discussing Intellectual Property protection in the field of Pharmaceuticals.
Recombinant Antibodies
Dr. Haanes will present, "The Role of Patented Research Tools in the Advancement of Antibody Therapeutics." The presentation will consider what impact the Integra decision could have on the therapeutic antibody industry and address how various categories of research tools used in the discovery, development, and testing of therapeutic monoclonal antibodies have been patented. Additionally, various theories regarding the patenting of research tools in the biotechnology industry will be discussed.
Reigning in the Patent System - Recent Efforts at Patent Reform
Significant Developments in Computer and Cyberspace Law Seminar
Robert G. Sterne will participating in a panel discussion entitled "Working With the Patent and Trademark Office...A Look Ahead."
Software IP Strategy Summit
Please join Mr. Sterne for a panel discussion on the topic, "Managing and Monetizing Your Portfolio".
Standards Setting & Patent Pools (Law Seminars International)
Dr. Goldstein will co-chair the two-day seminar October 17-18.
Stem Cell Research Challenges: Obstacles to Overcome when Entering the Stem Cell Therapeutics Field
Dr. Esmond will present a poster entitled, "Will Stem Cell Patents Block the Development and Commercialization of Stem Cell Therapies."
Strategies for Applying the New Patent Rules to Your IP Portfolio
Join us for a 90-minute discussion on strategies for patent prosecution under the new rules promulgated by the United States Patent and Trademark Office (USPTO). These rule changes significantly restrict or alter prosecution options in a wide range of areas including continuing application practice, claims examination, and commonly-owned, related patents. This webinar is intended to be very practical. Strategies in different scenarios involving pending and future filings, and potential pitfalls will be discussed.
The 12th Annual Forum on Biotech Patenting
Dr. Esmond will present, "The Patenting of Stem Cells."
The 2006 Midwest Intellectual Property Institute
Please join Dr. Cimbala and Mr. Ray for an informative panel, "How to Respond to PTO Patentability Rejections: Top 10 Tactics and More."
The 43rd ACNP Annual Meeting
As an invitee of the American College of Neuropsychopharmacology, Dr. Goldstein will participate in a workshop on federal programs to facilitate drug discovery.
The 5th Annual University of Baltimore Intellectual Property Law Symposium
Ms. Floyd will present, "Natural Resources in Biotechnology."
The ABA Section on Intellectual Property Law presents Practical Tips on Intellectual Property Law
Ms. Durkin will co-present, "Online Trademark Enforcement Strategy." The discussion will touch on:
The Cleantech Forum XII
Mr. Cornwell will participate in a panel discussing the, "Future of Transport: Scalable Transportation Technologies & the SmartGrid."
The Emerging Role of the Chief IP Officer (CIPO)
Join Robert Greene Sterne and Ron Laurie as they discuss why the formation of a CIPO (Chief IP Officer) is needed now: to address the emerging importance of intellectual property to corporate profitability. They will also discuss the decisions on which the CIPO should weigh in.
The Essentials of an Effective Corporate IP Program and Putting an IP Program into Action
The emphasis of the presentation by Tracy Durkin and Melissa Sellers is threefold:
The Impact of Post-KSR Court Decisions and PTO Guidelines on Obviousness Issues
Dr. Elizabeth J. Haanes will be participating on a panel discussing the new PTO guidelines and the recent Board decisions.
The National Forum on Biotechnology & Pharmaceuticals
Dr. Goldstein will present "A Legal Policy Analysis on the Patenting of Human Genes."
The Patenting of Stem Cells and Ethical Issues
The Secretary's Advisory Committee on Genetics, Health and Society
Dr. Goldstein will present a "Primer on Intellectual Property" during the Session on Gene Patents and Licensing Practices.
The Sedona Conference®
Ken Bass is a Faculty Member for The Sedona Conference®. The Conference is October 12-13 in Sedona, Arizona. Mr. Bass will sit on the following panels:
The Sedona Conference® Institute: Report on Markman Hearings & Claim Construction
Please join us as we host The Sedona Conference Institute® in association with AIPLA - Markman Hearings & Claim Construction in Patent Litigation: A Public Forum on The Sedona Conference® Report on Markman Hearings. For more information, please visit www.thesedonaconference.org
The Sedona Conference®, Patent Litigation VIII
The Sedona Conference® on Patent Litigation VIII will be held October 11-12, 2007. Rob Sterne co-chairs this event.
The University of Akron School of Law's Fifth Annual Intellectual Property Law Symposium
Panel Discussion: Fifty Years Under the Patent Act of 1952: A Glance Back - A Look Ahead
Trade Dress Forum: Dress for Success
Ms. Durkin will moderate a panel discussing, "Legal Tests for Establishing Protection for Trade Dress."
Trade Dress Law: Where Do We Go From Here?
With TrafFix Devices, Samara Bros., and the Trademark Amendments Act, trade dress jurisprudence has undergone significant changes in recent years. This panel will attempt to put these changes into perspective, and provide practical tips on counseling clients and litigating trade dress issues.
Trademark Administrators Conference 2005
Ms. Durkin will co-present with Cheryl Tubach of The Coca-Cola Company on "Other Forms of Intellectual Property: There is Another World Out There."
Turning Your Passion into Profit: A Conference on the Entrepreneurial Spirit
VAULT/MCCA 2007 Legal Diversity Career Fair
Washington Academy of Sciences Forum - Nanotechnology: An Interdisciplinary Endeavor
Mr. Specht will present, "Overview of Commercial Sector Activity in Interdisciplinary Nanotechnology."
Women of Color in Law Firms: Pathways to Success for All
Sterne Kessler will be sponsoring this event which is dedicated to exploring the challenges surrounding the retention and development of minority women attorneys.
World Vaccine Congress 2008
Dr. Elizabeth Haanes will be participating in a panel discussing vaccine partnerships and intellectual property management. The following topics will be discussed:
Appellate
The primary requirement of a successful appellate attorney is an ability to see the case the way the appeals court is likely to see it. Appellate practice requires a unique skill set and effectiveness on appeal depends on sound logic, analysis and writing skills. We have experienced appellate attorneys who can present our client's cases with an understanding of the appellate judge’s viewpoint. We bear in mind that the mindset of the appellate judge is different than the trial judge and that an appeal is not a continuation of a trial, but a new proceeding founded on very different rules.
Biotechnology
We are one of the premier intellectual property law firms in the world with expertise in the area of biotechnology, having practiced in the field for over twenty years. We prepare and prosecute patent applications before the U.S. and foreign patent offices, conduct interferences, oppositions, arbitrations, litigations (both as counsel and expert witnesses), advise worldwide biotechnological clients on intellectual property strategy, trade secrets, evaluation of patent portfolios, acquisitions, and employment agreements.
Business Methods
We work with emerging and established companies to protect their valuable business methods. Often a client’s biggest asset is its proprietary method of doing business. The U.S. Patent and Trademark Office grants patents to provide protect for these business methods, so that our clients can exclude their competitors from doing business in the same way.
Chemistry
We work with our clients to develop a tailored strategy for building a patent portfolio that results in a solid business foundation, and, ultimately increased market value. We prepare and prosecute patent applications for our clients and coordinate with foreign associates to obtain patents and maintain consistency in protection abroad. Our chemical patent attorneys conduct risk, validity and infringement analyses in order to counsel clients as to whether patent properties should be appropriately enforced, the likelihood of infringement and how to steer clear of potential infringement.
CleanTech Industry Group
Clean technology or cleantech has been defined as a diverse range of products, services, and processes that are designed to provide superior performance at lower costs, greatly reduce or eliminate environmental impacts and, in doing so, improve the quality of life. Our CleanTechSM Industry Group serves a diverse range of technology clients with products, services, and processes targeting:
Client Counseling
We provide strategic counseling services to our clients, keeping in mind the need to maximize shareholder value. We counsel in such areas as:
Design Patents
There are few, if any law firms in the country with more experience in procuring and enforcing design patents. As a pioneer in this field, we were one of the first firms to challenge the conventional wisdom that cloaked the perception of design patents. Historically, there were two complaints lodged against the design patent system: design patents take too long to get and their scope is too narrow. By developing close relationships with the design examiners at the U.S. Patent & Trademark Office and by understanding what causes examination delay, our design patent attorneys can quickly and effectively usher patent applications through the system. Through our close relationship with design examiners, we have educated them about the importance of design patents and the need to have patents issue quickly. These efforts have, in part, been responsible for a new examination system that provides more rapid examination.
Electrical
The focus of our electrical practice is on the optimal use of intellectual property to increase shareholder value. To maximize shareholder value, we have evolved a renaissance IP lawyer model where expertise in members of the team is not limited to procurement or enforcement, but extends to optimizing IP protection, technology transfer and counseling.
Hatch-Waxman: Generic & Proprietary
An Abbreviated New Drug Application (ANDA) contains data which when submitted to the Food and Drug Administration (FDA), provides for the review and ultimate approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, low cost alternative to the American public.
Intellectual Property Valuation
A key factor in the valuation of a target company, for example, in connection with an acquisition or merger, is intellectual property valuation, or the value of any intellectual property owned by the target company. Intellectual property (including inventions, patent applications, patents, trade secrets, trademarks, copyrights, licensed-in technology, licensed-out technology, and the like) can account for a large percentage of a target company's value. Conversely, exposure to claims of patent infringement, trademark infringement or assertions of trade secret misappropriation can detract from the value of a target company.
Interferences
Competent and cost conscious legal representation in this complex area of patent law requires a keen understanding of the technology, the substantive law of interferences and - quite critically - interference procedure. We have had extensive and successful involvement in many interferences, and offer a cost effective, seasoned and knowledgeable team to handle interferences when they arise.
Internet
Our Internet practice focuses on all aspects of intellectual property on the Web. We assist our clients in Web site development, including obtaining trademark and copyright protection for Web site content, domain name registration, and patent protection for Internet business models. We also assist our clients when their intellectual property rights are being infringed on the Internet. We have worked on matters such as
Inventorship Dispute Resolution
As an alternative to often costly litigation, Sterne, Kessler, Goldstein & Fox offers inventorship dispute resolution services to non-client, private and public parties facing disputes and possibly litigation over inventor rights issues. This service provides specialized patent experts from Sterne Kessler, who act as credible and neutral third-parties in resolving inventor disputes efficiently and economically without having to go to court.
Litigation
Our litigation practice is grounded in the belief that it is our client’s business goals and needs that drive the strategy and tactics of a dispute. Rather than use a template approach to litigation, we know that each client is different and the litigation needs of our individual clients are diverse. These needs form the foundation on which we build a tailored litigation plan that ultimately has the best chance of resulting in a successful solution for our clients.
Mechanical
We use the full scope of IP protection to creatively and strategically protect our clients' innovations. We know that each client is unique and has a diverse set of needs. We tailor our approach according to those needs and develop a comprehensive strategy, using all available forms of IP protection, including utility and design patents, trade dress, trademarks, trade secrets, copyright, technology transfer and litigation.
Medical Devices
Our medical device practice optimizes the full scope IP protection from patent prosecution to medical device patent litigation. We approach each client from its own unique perspective and develop a comprehensive IP strategy using all available forms of IP protection. We are keenly aware of the interplay between the FDA approval process and the patent process, and we work with our clients to make sure that statements made in their FDA filings will not affect their IP protection.
Nanotechnology
We have a long history of representing the IP needs of clients within nascent industries, such as biotechnology, bioinformatics, and software. Based on our experience, it is critical for companies in an emerging industry to secure strong intellectual property portfolios in a cost effective and expeditious manner.
Opposition/Cancellation
We have extensive experience in developing strategies to help our clients avoid infringing competitors' patents. One means of avoiding infringement damages is to have the patent declared invalid during an opposition/cancellation proceeding. We frequently analyze the validity of a competitor's patents or applications in the US and/or elsewhere. Once we determine that the patent is invalid, a cost effective way to obtain a similar determination from a court or patent office is to file an opposition or cancellation request.
Patent
In the area of patent law, our client base is broad, including individual inventors, emerging companies and Fortune 500 companies; spread across the U.S. and across the globe. The patents that we acquire for them are sometimes their most important assets.
Pharmaceuticals
In today's competitive landscape, strong patent protection is critical in bringing pharmaceuticals to market. We understand the challenges and risks faced by our clients and strive to provide high value counseling. A strategy is only as good as its execution. Our attorneys and agents have drafted and prosecuted hundreds of patent applications in the field of pharmaceuticals. We've also developed expertise in identifying additional patentable inventions as a new chemical entity works its way through the development process.
Software
We have been and continue to be a pioneer in the field of software patent protection. We were lead counsel for IBM in the landmark In re Beauregard appeal to the Federal Circuit, which resulted in the issuance of the Software Patent Guidelines by the U.S. Patent and Trademark Office.
Stem Cells
In keeping with our tradition of providing intellectual property (IP) counsel to those working in leading edge technologies, our firm formed in the Autumn of 2004, a Stem Cell Task Force. The Task Force, which is staffed by firm members with experience in the IP of stem cells, is staying abreast of legal and policy developments, and has defined, as its principal mission, to keep our clients and friends informed and up to date in this exciting field.
Technology Transfer
Technology transfer involves the strategic transfer of rights in proprietary technologies. The long-term viability of virtually every technology company is determined largely by how effectively that company protects and leverages its intellectual property. A thorough understanding of both the particular technology at issue in a transaction and the legal framework governing the transfer of rights in that technology is critical to a successful deal.
Trade Secret/Unfair Competition
One of the greatest challenges faced by many companies is the tension created between the patent laws and the law of trade secrets. In simple terms, a trade secret is something that is not generally known to the public, giving the possessor of such information a competitive edge or market advantage. Patent law requires disclosure of ideas in exchange for a period in which the patentee can prevent others from using an idea, thus a conflict of philosophy is born.
Trademark
Service is not just a buzzword we use. It is a defining part of our trademark practice. Our clients enjoy a team-oriented approach to service unparalleled in the IP community. Here is what distinguishes us from the competition:
Marianne Adams, Legal Assistant
Ms. Adams is a legal assistant in the Electronics Group where she performs a wide range of tasks in support of the prosecution of patent applications.
Prior to joining Sterne Kessler, she worked as a litigation paralegal, researching medical histories and preparing and managing medical device malfunction cases for class action lawsuits.
While in college, Ms. Adams minored in Criminal Justice and gained experience in the criminal law field in at the Ninth Circuit Solicitor's Office.
Omar F. Amin, Patent Agent
Mr. Amin assists in the preparation and prosecution of patent applications.
Thomas G. Annick, Director of Finance/Chief Financial Officer
Mr. Annick has 20 years of experience in corporate accounting and finance. After beginning his career as an auditor with a national accounting firm he became the chief accounting officer of a high tech NASDAQ-traded company. Later, he served for five years as the controller of a large, multinational law firm headquartered in Washington, DC. Prior to joining the firm in 2003, he was the CFO of several venture-funded startups including an Internet company that he helped found.
Shovon I. Ashraf, Technical Specialist
Dr. Ashraf participates in preparing validity, infringement, freedom-to-operate, and patentability opinions; writing and prosecution of U.S. and foreign patent applications; carrying out due diligence investigations; interference, and evaluating patent portfolios.
Gaurav Asthana, Patent Agent
Mr. Asthana assists in the preparation and prosecution of patent applications. He also assists in the analysis of patents for infringement, validity, due diligence, and re-examination as well as the analysis of intellectual property portfolios to help identify licensing strategies.
Robert E. Bakin, Registered Patent Agent
Dr. Bakin assists in patent analysis and freedom to operate issues. His scientific background is weighted toward mammalian signal transduction and the molecular mechanisms of oncogenic progression.
Randall K. Baldwin, Associate
Mr. Baldwin uses his extensive software engineering background to help clients obtain patent protection for their inventions. He prepares and prosecutes patent applications in a broad variety of technical fields including computer software, telecommunications, e-commerce, and Internet applications. Mr. Baldwin is responsible for the procurement of intellectual property and serves clients' intellectual property needs in technical subject matter areas including software, communications, electronics, computers, biometrics, and business methods.
Donald R. Banowit, Director
Mr. Banowit's intellectual property practice includes patent litigation and interference matters, the preparation and prosecution of applications before the U.S. and foreign patent offices, patentability investigations and non-infringement and validity opinions.
Kenneth C. Bass, Of Counsel
Mr. Bass began his legal career clerking for Justice Hugo Black of the Supreme Court. In the past 35 years, he has briefed and argued cases in federal and state courts across the country. Mr. Bass was co-counsel for Teleflex in KSR v. Teleflex, the most significant Supreme Court decision in patent law in the past 40 years. He was one of the authors of the petitioner's brief in Wal-Mart v. Samara, where the Supreme Court unanimously reversed the Second Circuit and established a significant principle for trade dress protection. He was a principal author of AWH's brief in Phillips v. AWH that involves reconsideration of all of the significant principles of patent claim construction.
Brian K. Baxter, Legal Assistant
Mr. Baxter has over 10 years of experience in prosecution and litigation and he assists in the preparation and prosecution of design patents. Mr. Baxter has assisted in litigation before several Federal District Courts, the Federal Circuit, Board of Patent Appeals and Interferences and the U.S. International Trade Commission. Additionally, he is also responsible for many tasks relating to the prosecution of utility patents and litigation.
Salvador M. Bezos, Associate
Mr. Bezos assists in the preparation and prosecution of patent applications. His technical expertise covers many areas of computer technology, from software to digital hardware.
Vikas Bhargava, Technical Specialist
Mr. Bhargava assists in the preparation and prosecution of patent applications.
Anna S. Blum, Legal Assistant
Ms. Blum is a Legal Assistant in the Electronics Group where she performs a wide range of tasks in support of the prosecution of patent applications.
Julie L. Blum, Patent Agent
Dr. Blum assists in the preparation and prosecution of patent applications as well as assisting in the research and preparation of patentability, infringement and validity opinions. Her areas of technical experience include biotechnology, chemistry and pharmaceuticals.
Cynthia M. Bouchez, Associate
Dr. Bouchez's practice includes counseling clients on a wide variety of patent procurement and enforcement issues and intellectual property strategy. She prepares validity, infringement, freedom-to-operate and patentability opinions. Dr. Bouchez also has significant experience in writing and prosecuting U.S. and foreign applications on complex technologies in a variety of scientific fields.
Katrina Braden-Elliott, Foreign Filing Manager
Ms. Braden-Elliott manages the firm's highly skilled Foreign Filing Department. This department, consisting of 19 talented individuals with a collective 140 years of experience, is responsible for attending to all aspects of formality requirements for foreign matters.
Ms. Braden-Elliott is a patent professional with a diverse background in patent administration, which includes U.S. and foreign patent prosecution. She is involved with the PCT Roundtable and regularly attends PCT seminars to ensure that firm members stay abreast of the latest changes and updates concerning PCT and foreign patent law. She is a committed leader focused on providing the highest level of quality and service to all firm clients.
Ms. Braden-Elliott held key positions within the foreign filing departments of other large law firms prior to joining Sterne Kessler.
Lori M. Brandes, Associate
Dr. Brandes assists in the preparation and prosecution of U.S. and foreign patent applications. She also assists in the research and preparation of validity, infringement and patentability opinions and provides litigation support.
Kathleen Buckley Kalafus, Technical Specialist
Dr. Kalafus is a technical specialist in the Biotechnology/Chemical Group. She assists in the preparation and prosecution of U.S. and foreign patent applications, the preparation of patentability, validity, and non-infringement opinions, and provides litigation support. Her technical expertise is in the areas of genetics, molecular biology, microbiology and biochemistry.
Dr. Kalafus' graduate research was focused on chromosome maintenance in eukaryotes and more particularly on the mechanistic features of telomere replication and regulation. Dr. Kalafus also has extensive experience in the field of cancer biology.
Robert K. Burger, Chief Operating Officer
Mr. Burger is responsible for furthering the firm's strategic and financial objectives and ensuring that the firm's operations support the building of successful practices.
Mr. Burger has nearly twenty years of legal work experience, having held positions of responsibility both at national law firms as well as with the government. In 1995, Mr. Burger received the Attorney General's Award for excellence in administration.
Vaughan W. Butts, Chief Information Officer
Mr. Butts has over 16 years of experience in the field of Information Technology with 8 of those years in the legal field. He has provided strategic, technical and operational leadership in the areas of network operations, help desk, litigation support, training, application development and telecommunications. In addition, Mr. Butts fosters a strong commitment to providing quality service in a professional manner.
Paul A. Calvo, Associate
Dr. Calvo is involved in writing and prosecuting U.S. and foreign patent applications, as well as contributing to the preparation of infringement and patentability opinions.
Christian A. Camarce, Associate
Mr. Camarce is an associate in the Electronics Group. He assists in the preparation and prosecution of patent applications. He has extensive technical experience in analog integrated circuit design, Flash memory, and semiconductor device fabrication.
Prior to joining Sterne Kessler, Mr. Camarce was a senior design engineer for a world leader in semiconductor technology. His work focused on the research, design, and validation of analog integrated circuits on multiple generations of Flash memory products.
Mr. Camarce is admitted to practice only in the state of Virginia.
Vincent L. Capuano, Director
Dr. Capuano's practice is focused in the chemical and pharmaceutical area, where he counsels clients in all areas of patent procurement, exploitation and enforcement, including domestic and foreign patent preparation and procurement, patent validity and infringement analysis, patent licensing and FDA/ANDA practice.
Helene C. Carlson, Associate
Dr. Carlson’s intellectual property experience includes the preparation and prosecution of U.S. and foreign patent applications; the preparation of materials for interference proceedings; the negotiation of licensing agreements, confidentiality agreements, and PHS Cooperative Research and Development Agreements; and preparing validity, infringement, and patentability opinions.
Kristina L. Carroll, Technical Specialist
Dr. Carroll is a technical specialist in the Biotechnology/Chemical group. She assists in the research, preparation, and prosecution of U.S. and international patent applications. She also contributes to the research and preparation of patentability, validity, and non-infringement opinions. Her areas of technical experience include molecular biology, genetics, biochemistry, and biotechnology.
Shannon A. Carroll, Associate
Dr. Carroll assists in the preparation and prosecution of patent applications and in the preparation of validity, infringement, freedom to operate and patentability opinions. Her areas of expertise include microbiology, molecular biology and genetics.
Sabarni K. Chatterjee, Technical Specialist
Dr. Chatterjee is a technical specialist, in the Biotechnology/Chemical Group. His technical expertise includes biochemistry, cell biology, molecular biology, bioorganic chemistry, immunology, biomarkers, small-molecule drug design and cancer diagnostics and therapeutics, antibody therapeutics and diagnostics and cancer vaccines.
Prior to joining Sterne Kessler, Dr. Chatterjee was a Senior Fellow-Marketing and Licensing, at the Office of Technology Transfer, National Institutes of Health. At NIH, he was involved in intellectual property management, marketing and licensing of NIH technologies. He provided written opinions regarding patent prosecution strategies and had been part of the negotiations in several license agreements between NIH and private industry.
Michele A. Cimbala, Director
Dr. Cimbala's practice involves biotechnology patent procurement and evaluation, including the preparation of patent applications, their prosecution and appeal, and related opinion matters. She has significant experience in the areas of:
W. Blake Coblentz, Associate
Mr. Coblentz is a member of the firm's Litigation Group and Biotechnology/Chemical Group. His practice includes representing clients in district court litigation; representing clients in interferences before the United States Board of Patent Appeals and Interferences; preparing patentability, infringement and invalidity opinions; representing clients in reexamination proceedings; and preparing and prosecuting U.S. and foreign patent applications. Mr. Coblentz's district court litigation and interference experience includes client counseling, motions practice, depositions and brief writing.
Mr. Coblentz's intellectual property experience has been principally in areas such as biochemistry, molecular and cell biology, gene synthesis, recombinant DNA technology, immunology, therapeutic methods, pharmaceuticals, diagnostic assays, and vaccines.
Richard D. Coller, Associate
Mr. Coller focuses his practice on patent litigation and the preparation and prosecution of U.S. and foreign patent applications.
Prior to joining Sterne Kessler, Mr. Coller worked as a law clerk in the corporate legal group of a multinational software analytics company. Mr. Coller has also worked as a university research assistant in the field of surgical implants, more specifically in developing biosensors for medical, environmental, and defense applications.
Mr. Coller is admitted to practice only in the state of Virginia.
Gena N. Collins, Legal Assistant
Ms. Collins has over 20 years of experience in all aspects of litigation. She has worked in the law firm environment and as a contractor with the United States Department of Justice, Civil Division. Ms. Collins is responsible for assisting with filing complaints, docketing litigation activity and handling all aspects and phases of discovery. Additionally, she coordinates the creation of the firm's litigation database and performs monitoring and research.
James A. Cooke, Technical Specialist
Dr. Cooke prepares and prosecutes utility patent applications for mechanical devices, computer software, business methods, wireless technologies, and medical devices. Dr. Cooke also assists in the preparation of product clearance opinions and patent validity and infringement opinions.
David K.S. Cornwell, Director
Mr. Cornwell specializes in patent litigation in the fields of mechanical engineering, biotechnology, computers and related technologies. He has numerous offensive and defensive litigation to his credit in the fields of:
John M. Covert, Director
Mr. Covert's practice is focused in technologies that involve organic chemistry, such as pharmaceuticals, coatings, fuels, lubricants and pesticides. He is experienced in a number of interdisciplinary areas, including computer-aided drug design, combinatorial chemistry and medical devices. He provides counseling with regard to patent portfolio strategy and management with issues that range from licensing, collaborations and technology acquisitions, to patent validity, infringement and design around strategies.
Thea R. D'Ambrosio, Legal Assistant Coordinator
Ms. D'Ambrosio has over five years of experience in patent prosecution and assists in the preparation of interference matters. She also trains and reviews the work of recently hired legal assistants in her practice group as well as organizes and monitors their workload.
Anthony A. Davis, Facilities Manager
Mr. Davis is an office services/facility manager with over 21 years experience in maintenance and operations of law firms. He has strong managerial and leadership qualities backed by strong interpersonal and motivational skills that enbale him to produce a quality team of service clerks with one goal in mind, to provide quality service to the client.
Brian J. Del Buono, Director
Dr. Del Buono represents a diverse group of U.S. and international clients drawn from a variety of sectors of the biotechnology, pharmaceuticals, nanotechnology and chemicals industries. He provides counseling with regard to patent portfolio strategy and management for issues ranging from licensing, collaborations and technology acquisitions, to patent validity, infringement and design around strategies. In particular, Dr. Del Buono's practice focuses on U.S. and international patent procurement and enforcement (particularly patent prosecution, interferences, appellate advocacy and oppositions), patent validity and infringement investigations for ANDA filings under the Hatch-Waxman Act for both generic and proprietary pharmaceutical companies, and working with industrial clients on the intellectual property aspects of corporate strategic planning and product lifecycle management. He also has experience in the valuation and licensing of intellectual property, IP due diligence investigations, and providing opinions relating to patent infringement, validity and freedom-to-operate.
Cynthia L. DeRenzo, Patent Agent
Dr. DeRenzo is a Patent Agent in the Biotechnology/Chemical Group. She assists in the preparation and prosecution of U.S. and foreign patent applications and in the research and preparation of patentability, validity, and infringement opinions. Her areas of technical expertise include genetics, molecular biology, biochemistry, and cellular biology.
LuAnne M. DeSantis, Associate
Ms. DeSantis prepares and prosecutes patents involving diverse technologies. She has worked on intellectual property matters involving microprocessors, telecommunication systems and computer software applications. Ms. DeSantis has also been involved in drafting technology licensing agreements, conducting due diligence technology portfolio assessments for mergers and acquisitions and assisting on validity and infringement opinions.
Matthew J. Dowd, Associate
Mr. Dowd is involved in the strategic development of patent portfolios for companies, including the prosecution of U.S. and foreign patent applications. He provides support in developing patentability opinions, IP due diligence analyses, and infringement and validity analyses. Mr. Dowd also has experience in providing assistance for patent litigation matters, including district court and PTO interference matters.
Timothy A. Doyle, Associate
Mr. Doyle drafts and prosecutes patent applications relating to a variety of technologies. These include analog filters, operational amplifiers, delta sigma modulators, MOSFET biasing circuits, switched capacitor circuits, digital image processing, computer graphics, graphical systems for data analysis, microstructure (MEMS) fabrication, optical MEMS, optical beam shaping, laser coherence testing, bioreactors, and business performance forecasting. In addition to prosecution practice, he supports intellectual property due diligence projects for litigation and for business acquisition, and provides client counseling regarding the use of electronic lab notebooks.
Haixia Du, Technical Specialist
Dr. Du is involved in the research and analysis of patentability as well as the preparation and prosecution of patent applications. Her areas of technical experience include computer software, graphics user interface, multimedia, and networking.
Tracy-Gene G. Durkin, Director
Ms. Durkin has over twenty years of experience obtaining and enforcing worldwide intellectual property rights, including utility and design patents, trademarks and copyrights. Ms. Durkin’s client counseling experience includes helping clear new products and trademarks for use in the marketplace, selecting appropriate IP protection, and enforcing such protection through mediation, litigation and licensing. Her expertise in design patents has helped clients successfully and cost-effectively eliminate copycat products from the marketplace. In addition, Ms. Durkin has represented clients in Patent, Trademark and Copyright disputes before Federal District Courts, the Court of Appeals for the Federal Circuit, the International Trade Commission, the U.S. Patent & Trademark Board of Patent Appeals and Interferences, and the Trademark Trial and Appeal Board. She has successfully represented both complainants and respondents before the World Intellectual Property Office in domain name arbitrations. Her prior experience working at the U.S. Patent and Trademark Office makes her especially effective at arguing difficult cases and negotiating with Examiners in personal interviews.
Jason D. Eisenberg, Associate
Currently, Mr.